IL-17F Promotes Tissue Injury in Autoimmune Kidney Diseases

J Am Soc Nephrol. 2016 Dec;27(12):3666-3677. doi: 10.1681/ASN.2015101077. Epub 2016 Mar 30.

Abstract

The TH17 immune response has a central role in the pathogenesis of autoimmune diseases, implicating the TH17 master cytokine, IL-17A, as the critical mediator of diseases such as human and experimental crescentic GN. However, the relative importance of additional TH17 effector cytokines, including IL-17F, in immune-mediated tissue injury remains to be fully elucidated. Here, using a mouse model of acute crescentic GN (nephrotoxic nephritis), we identified CD4+ T cells and γδ T cells as the major cellular source of IL-17F in the inflamed kidney. Interventional studies using IL-17F gene-deficient mice, IL-17F-neutralizing antibodies, and adoptive transfer experiments into Rag1-/- mice demonstrated that CD4+ T cell-derived IL-17F drives renal tissue injury in acute crescentic GN. Notably, IL-17F-deficient nephritic mice had fewer renal infiltrating neutrophils than wild-type nephritic mice, and neutrophil depletion did not affect the course of GN in IL-17F-deficient mice. Moreover, in the chronic model of pristane-induced SLE, IL-17F-deficient mice developed less severe disease than wild-type mice, with respect to survival and renal injury. Finally, we show that IL-17F induced expression of the neutrophil-attracting chemokines CXCL1 and CXCL5 in kidney cells. The finding that IL-17F has a nonredundant function in the development of renal tissue injury in experimental GN might be of great importance for the development of anti-IL-17 cytokine therapies in TH17-mediated human autoimmune diseases.

Keywords: cytokines; glomerulonephritis; immunology; lymphocytes; systemic lupus erythematosus.

MeSH terms

  • Animals
  • Autoimmune Diseases / etiology*
  • Autoimmune Diseases / pathology
  • Glomerulonephritis / immunology*
  • Glomerulonephritis / pathology
  • Interleukin-17 / physiology*
  • Male
  • Mice
  • Neutrophils

Substances

  • Interleukin-17